Citi Opens Rocket Lab Coverage With a Buy as Synspective Deal Lifts the Order Book Past 100 Missions
Published on 10/05/2026 at 12:02 | Editorial boerse-global.de
Rocket Lab picked up fresh momentum on two fronts this week, with a bullish initiation from Citigroup landing alongside confirmation of the company's largest commercial Electron contract to date.
Citi began covering the stock on Thursday with a Buy rating and a $105 price target, according to media reports. The shares were changing hands at EUR 66.20 on the day, a gain of 0.8% from the previous close. Friday brought a stronger move, with the stock climbing 4.6% to EUR 65.70 as the market digested the Synspective agreement.
Synspective Commits to 20 More Electron Flights
Under the newly signed deal, Rocket Lab will fly 20 Electron missions for the Earth-observation specialist between 2028 and 2031, with launches scheduled on an annual basis. The arrangement lifts Synspective's total manifest to 47 booked missions and pushes Rocket Lab's overall backlog beyond the 100-mission mark.
That kind of multi-year visibility carries outsized weight in a capital-hungry industry, where securing launch slots years ahead lets an operator scale production, absorb fixed costs and deepen ties with customers. It also serves as a public vote of confidence in Electron, which has cemented its reputation as a dependable workhorse for small-satellite operators. Financial terms of the contract were not disclosed.
Should investors sell immediately? Or is it worth buying Rocket Lab?
Iridium Shareholders Back the Takeover
Beyond its organic pipeline, Rocket Lab is pressing ahead with a transformational acquisition. Roughly a week ago, shareholders of Iridium Communications voted approximately 99.6% in favor of being acquired by the launch company. The transaction still hinges on regulatory clearances and other closing conditions, but if completed as planned it would hand Rocket Lab valuable capabilities in space-based communications.
CFO Spice Trims His Stake
One note of caution arrived on Thursday, when Chief Financial Officer Adam C. Spice sold 140,157 shares, a move disclosed in a mandatory filing submitted Friday. The disposal was executed through a pre-arranged 10b5-1 trading plan, following the exercise of options at a strike price of $1.09 apiece.
Transactions of this type are routine among executives at US growth companies, and market participants generally read them as personal liquidity or portfolio-diversification decisions rather than a verdict on the business. Even so, insider sales after a share-price run-up can leave more cautious investors uneasy.
Valuation Still Well Below Its Peak
What the fundamentals ultimately rest on is how efficiently Rocket Lab converts its contracted backlog into revenue and how reliably it executes upcoming missions. The company carries a market capitalization of EUR 35.94 billion, yet the stock trades about 51% below its 52-week high — a gap that helps explain the constructive stance from Citi.
For investors weighing the risk, the long-dated launch visibility and the potential of the Iridium deal carry more weight than the optics of the CFO's share sale, provided the pending approvals clear without complications.
Ad
Rocket Lab Stock: New Analysis - 5 October
Fresh Rocket Lab information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
